- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 7, 2025 | 11.34M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $2.49M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $2.4M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $1.27M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $613.55K |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $1.27M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $800.76K |
| Current Assets | Q1 2025 · Mar 31, 2025 | $3.65M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $3.35M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $3.72M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $3.68M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 6.5M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $5.62K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$800.75K |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $3.45M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $4.01M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.22 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.22 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $522.76K |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $277.55K |
| Net Income | Q1 2025 · Mar 31, 2024 | −$1.45M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$1.44M |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | $299.78K |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $1.45M |
| Revenue | Q1 2025 · Mar 31, 2024 | $1.75M |